X0407 4 2023-03-20 0 0001534133 CalciMedica, Inc. /DE/ CALC 0001484729 Leheny A. Rachel C/O CALCIMEDICA, INC. 505 COAST S. BLVD. #202 LA JOLLA CA 92037 1 1 1 0 Chief Executive Officer 0 Common Stock 2023-03-20 4 A 0 356989 A 356989 I By Valence Investments SPV IV, LLC Common Stock 2023-03-20 4 A 0 66228 A 66228 I By Valence Investments SPV V, LLC Common Stock 2023-03-20 4 A 0 316109 A 316109 I By Valence Investments SPV VI, LLC Employee Stock Option (right to buy) 2.44 2023-03-20 4 A 0 11232 A 2029-04-24 Common Stock 11232 11232 D Employee Stock Option (right to buy) 6.60 2023-03-20 4 A 0 76173 A 2030-01-23 Common Stock 76173 76173 D Employee Stock Option (right to buy) 6.60 2023-03-20 4 A 0 30381 A 2030-06-29 Common Stock 30381 30381 D Employee Stock Option (right to buy) 7.99 2023-03-20 4 A 0 13964 A 2031-04-27 Common Stock 13964 13964 D Employee Stock Option (right to buy) 7.99 2023-03-20 4 A 0 19826 A 2031-04-27 Common Stock 19826 19826 D Employee Stock Option (right to buy) 7.99 2023-03-20 4 A 0 13964 A 2031-06-30 Common Stock 13964 13964 D Employee Stock Option (right to buy) 10.42 2023-03-20 4 A 0 3552 A 2032-08-30 Common Stock 3552 3552 D Employee Stock Option (right to buy) 10.42 2023-03-20 4 A 0 2030 A 2032-08-30 Common Stock 2030 2030 D Employee Stock Option (right to buy) 10.42 2023-03-20 4 A 0 1062 A 2032-08-30 Common Stock 1062 1062 D Employee Stock Option (right to buy) 17.34 2023-03-20 4 A 0 1717 A 2033-03-19 Common Stock 1717 1717 D Employee Stock Option (right to buy) 17.34 2023-03-20 4 A 0 30443 A 2033-03-19 Common Stock 30443 30443 D Employee Stock Option (right to buy) 17.34 2023-03-20 4 A 0 12342 A 2023-03-19 Common Stock 12342 12342 D Warrant 27.94 2023-03-20 4 A 0 9935 A 2026-02-22 Common Stock 9935 9935 I By Valence Investments SPV V, LLC Warrant 27.94 2023-03-20 4 A 0 9935 A 2026-05-25 Common Stock 9935 9935 I By Valence Investments SPV V, LLC Received in exchange for an aggregate of 12,395,423 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC ("Valence IV"), Valence Investments SPV V, LLC ("Valence V") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the "Valence Securities"). The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein. Received in exchange for 2,299,564 shares of the common stock of CalciMedica pursuant to the Merger Agreement. Received in exchange for 10,975,977 shares of the common stock of CalciMedica pursuant to the Merger Agreement. 25% of the shares subject to the option vested on April 30, 2020 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter. Received in exchange for a stock option to acquire 390,000 shares of common stock of CalciMedica pursuant to the Merger Agreement. Received in exchange for a stock option to acquire 2,644,900 shares of common stock of CalciMedica pursuant to the Merger Agreement. 25% of the shares subject to the option vested on June 30, 2020 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter. Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. Received in exchange for a stock option to acquire 1,054,921 shares of common stock of CalciMedica pursuant to the Merger Agreement. Beginning on February 22, 2021, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments. Received in exchange for a stock option to acquire 484,863 shares of common stock of CalciMedica pursuant to the Merger Agreement. Immediately exercisable. Received in exchange for a stock option to acquire 688,404 shares of common stock of CalciMedica pursuant to the Merger Agreement. Received in exchange for a stock option to acquire 123,357 shares of common stock of CalciMedica pursuant to the Merger Agreement. Received in exchange for a stock option to acquire 70,490 shares of common stock of CalciMedica pursuant to the Merger Agreement. Received in exchange for a stock option to acquire 36,905 shares of common stock of CalciMedica pursuant to the Merger Agreement. Beginning on November 22, 2022, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments. Received in exchange for a stock option to acquire 59,641 shares of common stock of CalciMedica pursuant to the Merger Agreement. Received in exchange for a stock option to acquire 1,057,071 shares of common stock of CalciMedica pursuant to the Merger Agreement. Received in exchange for a stock option to acquire 428,566 shares of common stock of CalciMedica pursuant to the Merger Agreement. Received in exchange for a stock option to acquire 344,934 shares of common stock of CalciMedica pursuant to the Merger Agreement. By John Dunn, Attorney-in-Fact 2023-03-22